A clonal derivative of a transfectant of the SP2/0 myeloma cell line producing a chimeric monoclonal antibody was maintained in steady-state, continuous culture at dilution rates ranging from 0.21 to 1.04 day-'. The steady-state values for nonviable and total cell concentrations increased as the dil
Enhanced production and isotope enrichment of recombinant glycoproteins produced in cultured mammalian cells
β Scribed by David Skelton; Abbey Goodyear; DaQun Ni; Wendy J. Walton; Myron Rolle; Joan T. Hare; Timothy M. Logan
- Book ID
- 106401732
- Publisher
- Springer Netherlands
- Year
- 2010
- Tongue
- English
- Weight
- 382 KB
- Volume
- 48
- Category
- Article
- ISSN
- 0925-2738
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The recent approval of the recombinant DNA-derived biological, human tissue-type plasminogen activator (rt-PA), obtained from large scale mammalian cell culture, addressed a number of issues concerning the safety of recombinant products. The assurance of the safety of such highly complex proteins re
## Abstract We describe the expression and consistent production of a first targetβspecific recombinant human polyclonal antibody. An antiβRhesus D recombinant polyclonal antibody, Sym001, comprised of 25 unique human IgG1 antibodies, was produced by the novel Sympress expression technology. This s